Literature DB >> 1515940

Differential distribution of cellular forms of beta-amyloid precursor protein in murine glial cell cultures.

M Mizuguchi1, K Ikeda, S U Kim.   

Abstract

The production and localization of cell-associated forms of beta-amyloid precursor protein (APP) of Alzheimer's disease was investigated in primary cultures of mouse glial cells. In both oligodendrocytes and astrocytes, immunofluorescence staining with an antibody against the carboxy terminus of APP revealed an intense cytoplasmic immunoreactivity. Immunoblotting of the cell extracts detected differences in the composition of APP between oligodendrocytes and astrocytes, notably the abundance of 107 kDa subtype in oligodendrocytes. Differences in immunoblot patterns were also noted between two buffer-insoluble, membrane-rich subcellular fractions of the glial cells, nuclear-mitochondrial and microsomal; the 119 kDa APP was enriched in the former, whereas the 73 and 115 kDa APPs in the latter. The results suggest that each APP subspecies may play a distinct functional role in different cell types and subcellular fractions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1515940     DOI: 10.1016/0006-8993(92)90898-j

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.

Authors:  Vladimir Volloch; Bjorn Olsen; Sophia Rits
Journal:  Ann Integr Mol Med       Date:  2020

2.  Cytochrome c peroxidase activity of heme bound amyloid β peptides.

Authors:  Manas Seal; Chandradeep Ghosh; Olivia Basu; Somdatta Ghosh Dey
Journal:  J Biol Inorg Chem       Date:  2016-06-07       Impact factor: 3.358

3.  Lissencephaly gene product. Localization in the central nervous system and loss of immunoreactivity in Miller-Dieker syndrome.

Authors:  M Mizuguchi; S Takashima; A Kakita; M Yamada; K Ikeda
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

4.  Oligodendrocytes are a novel source of amyloid peptide generation.

Authors:  Stephen D Skaper; Nicholas A Evans; Nicholas A Evans; Claudia Rosin; Laura Facci; Jill C Richardson
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 5.  Abeta aggregation and possible implications in Alzheimer's disease pathogenesis.

Authors:  Prashant R Bharadwaj; Ashok K Dubey; Colin L Masters; Ralph N Martins; Ian G Macreadie
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

Review 6.  Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.

Authors:  Juan M Zolezzi; Sussy Bastías-Candia; Manuel J Santos; Nibaldo C Inestrosa
Journal:  Front Aging Neurosci       Date:  2014-07-28       Impact factor: 5.750

Review 7.  Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.

Authors:  Eric Tönnies; Eugenia Trushina
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers.

Authors:  Rodrigo Cataldi; Sean Chia; Katarina Pisani; Francesco S Ruggeri; Catherine K Xu; Tomas Šneideris; Michele Perni; Sunehera Sarwat; Priyanka Joshi; Janet R Kumita; Sara Linse; Johnny Habchi; Tuomas P J Knowles; Benedetta Mannini; Christopher M Dobson; Michele Vendruscolo
Journal:  Commun Biol       Date:  2021-01-04

9.  Structural progression of amyloid-β Arctic mutant aggregation in cells revealed by multiparametric imaging.

Authors:  Meng Lu; Neil Williamson; Ajay Mishra; Claire H Michel; Clemens F Kaminski; Alan Tunnacliffe; Gabriele S Kaminski Schierle
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

Review 10.  The effect of insomnia on development of Alzheimer's disease.

Authors:  Shaghayegh Sadeghmousavi; Mahsa Eskian; Farzaneh Rahmani; Nima Rezaei
Journal:  J Neuroinflammation       Date:  2020-10-06       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.